Dr. Bible is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 605-720-7171
Education & Training
Mayo Clinic College of MedicinePost-Doctoral Fellowship, 1995 - 1997- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1992 - 1995
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
University of Illinois at Urbana-ChampaignPhD, Chemistry, 1983 - 1989
University of Illinois College of MedicineClass of 1983
Washington University in St. LouisB.S./A.B., Chemistry&Anthropology, Phi Beta Kappa, 1976 - 1979
Certifications & Licensure
MN State Medical License 1990 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 1998 Dec 01
- Combination Chemotherapy in Treating Patients With Advanced Cancer Start of enrollment: 2001 May 01
- Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer Start of enrollment: 2008 Feb 22
- Join now to see all
Publications & Presentations
PubMed
- Pemetrexed-carboplatin salvage therapy in advanced thyroid cancers.Kenzie K Lee, John C Morris 3rd, Aditi Kumar, Ashish V Chintakuntlawar, Candy Peskey
Head & Neck. 2024-10-27 - 11 citationsRadiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase ...Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein
The Lancet. Oncology. 2023-02-01 - 41 citationsAmerican Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining...David C Shonka Jr, Alan Ho, Ashish V Chintakuntlawar, Jessica L Geiger, Jong C Park
Head & Neck. 2022-06-01
Press Mentions
Novel Treatments, Effective Combinations Still Needed in Thyroid CancerMay 26th, 2016
Study to Treat Deadly Form of Thyroid Cancer Shows PromiseApril 18th, 2013
Grant Support
- Flavopiridol Reverses Platinum Resistance In Ovarian CancerNational Cancer Institute2009–2011
- Chaetocin As A Potential Therapy For Multiple MyelomaNational Cancer Institute2008–2011
- Flavopiridol Targets Transcription Factor/Dna ComplexesNational Cancer Institute2004–2006
- Flavopiridol As A Potential Therapy In Multiple MyelomaNational Cancer Institute2004–2005
- Flavopiridol Targets Transcription Factor/Dna ComplexesNational Cancer Institute2003
- Flavopiridol As A Potential Therapy In Multiple MyelomaNational Cancer Institute2003
- Phase I: Flavopiridol And Cisplatin In Advanced CancerNational Center For Research Resources2000–2002
Professional Memberships
- Member
- Member, Anaplastic Thyroid Cancer Task Force and Guidelines Committee; Member, Thyroid Nodules and Differentiated Thyroid Cancer Task Force and Guidelines Committee; Member, Ethics Advisory Committee
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
